Aim: Here, we set out to establish whether endogenous γ-H2AX is a biomarker in triple-negative breast cancer. Methods: We explored the association of γ-H2AX with mutation status and sensitivity to 139 different anticancer drugs in up to 41 breast cancer cell lines. Further, we correlated γ-H2AX expression in breast cancer tumor tissues with telomere length. Results: γ-H2AX positive breast cancer cells exhibit more mutations, and - when p53 mutated - have shorter telomeres. In breast cancer patients γ-H2AX is also related to shorter telomeres, which was in turn associated with poorer prognosis of triple-negative breast cancer patients. Conclusion: Thus, endogenous γ-H2AX is associated with short telomeres, which might offer a specific target for therapy for triple-negative breast cancer patients.

Additional Metadata
Keywords breast neoplasm, phosphorylated histone 2AX, telomere dysfunction, triple negative
Persistent URL,
Journal Biomarkers in Medicine
Rights no subscription
Nagelkerke, A, van Kuijk, S.J.A, Martens, J.W.M, Sweep, F.C, Hoogerbrugge, N, Bussink, J, & Span, P.N. (2015). Poor prognosis of constitutive γ-H2AX expressing triple-negative breast cancers is associated with telomere length. Biomarkers in Medicine, 9(4), 383–390. doi:10.2217/bmm.15.2